Patent · US Active

Solid state forms of a quinazoline derivative and its use as a BRAF inhibitor

US9718810B2 · kind B2 · utility

2Cited by

4References

15Claims

0Family size

Assignee

Ignyta, Inc. · US

Inventors

Stephen Bierlmaier · Towanda, US
Ralph C. Haltiwanger · West Chester, US
Martin J. Jacobs · West Chester, US

Key dates

Filing date	Apr 25, 2016
Grant date	Aug 1, 2017
Priority date	—
Expiry date	Apr 25, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This application relates to various salts and solid state forms of Compound (I). This application also relates to pharmaceutical compositions and therapeutic uses of these materials and compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.